Exagen Announces Acceptance of Multiple Abstracts at ACR 202

SAN DIEGO, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, announced today the acceptance of five abstracts at the 2023 American College of

Related Keywords

United States , San Diego Convention Center , California , San Diego County , San Diego , Ryan Douglas , United States Community Rheumatologist Practice , Exagen Inc , American College Of Rheumatology , Exchange Commission , Lupus Activity Monitoring Panel , Cell Bound Complement Activation Products , Poster Session , Longitudinal Evaluation , Real World Utility , United States Community Rheumatologist , Enhancing Systemic Lupus Erythematosus Diagnosis , Comparative Performance Characteristics , Antit Cell Antibodies , Blood Biomarkers , Step Towards Precision , Annual Report , Private Securities Litigation Reform Act ,